GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub
2026-03-12 - 08:37
Strategic investment reinforces Europe as a core pillar of GenScript’s global R&D and production network, following recent U.S. facility expansion. DELFT, Netherlands, March 12, 2026 /PRNewswire/ — GenScript announced the official opening of its first European mRNA production site in Delft, the Netherlands, marking a significant expansion of the company’s global mRNA platform and reinforcing Europe as
Share this post: